📖 Approx. 4 min
This article explains the key considerations for Regional Medical Collaboration Promotion Corporations in the context of business succession and medical M&A in dermatology, from a practical, hands-on perspective by M&A advisors specializing in the healthcare industry. We will cover specific countermeasures based on the revenue structures of general dermatology and cosmetic dermatology practices, and their utilization as an alternative to M&A.
1. Industry Background of Regional Medical Collaboration Promotion Corporations in Dermatology
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the management environment for medical institutions, including dermatology, has become increasingly challenging in recent years due to a combination of factors such as revisions to medical fees, rising labor costs, and the burden of capital investment. Interest in third-party succession M&A is growing, particularly from the perspective of the revenue structures of general and cosmetic dermatology practices.
Simultaneously, Regional Medical Collaboration Promotion Corporations are an important consideration in medical M&A practices. By appropriately structuring their use as an alternative to M&A, succession that benefits both the seller and the buyer can be achieved.
2. Key Practical Points
- Preparation: Organize dermatology-specific workflows, patient base, and equipment status, and clarify transfer conditions.
- Business Valuation: Calculate an appropriate valuation range based on the characteristics of the medical specialty. For dermatology, the revenue structures of general and cosmetic dermatology are key to valuation.
- Design of Regional Medical Collaboration Promotion Corporation: Select the optimal scheme, considering its use as an alternative to M&A. Verification from tax, legal, and labor perspectives is also necessary.
- Target Search and Matching: Identify suitable acquiring candidates from a nationwide network that align with the specialty’s characteristics. Carefully coordinate desired conditions.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and medical practice perspectives. Confirm dermatology-specific licenses and facility standards.
- Final Agreement and Closing: Conclude the final agreement, including representations and warranties, and indemnification clauses. Proceed in parallel with the transfer of licenses and staff communication.
3. Specific Considerations for Dermatology
In medical M&A for dermatology practices, the revenue structures of general and cosmetic dermatology hold the key to successful succession. There are numerous specific issues related to the characteristics of the specialty, such as the continuity of the patient base, employment of staff (doctors, nurses, paramedical staff), condition and renewal plans for equipment, and maintenance/acquisition of facility standards.
Furthermore, strategic planning that considers the unique market characteristics of dermatology, such as the composition of insured and self-pay medical services, the status of regional medical collaboration, and relationships with neighboring competing medical institutions, is important. We leverage our experience in supporting dermatology practice successions to provide practical support from an industry-specialized perspective.
4. Detailed Practicalities of Regional Medical Collaboration Promotion Corporations
Regional Medical Collaboration Promotion Corporations are an area requiring specialized consideration in medical M&A. Structuring their use as an alternative to M&A is key to success.
- Review of Relevant Laws and Practical Standards: Compliance with the Medical Care Act, tax laws, and labor laws.
- Collaboration with Experts: Cooperation with certified public accountants, tax accountants, lawyers, and labor and social security attorneys.
- Risk Assessment: Identification of potential risks and formulation of countermeasures.
- Consensus Building Among Parties: Designing terms that are satisfactory to both the seller and the buyer.
- Appropriate Documentation: Explicitly stating terms in the Letter of Intent and the Final Agreement.
Frequently Asked Questions
Q. What documents are required for consultation?
A. To facilitate a smooth process, please prepare documents such as financial statements for the last three fiscal years, patient number trends, staff composition, equipment lists, and lease agreements (if applicable) in advance. We will receive these after signing an NDA.
Q. What is the general price range for dermatology practice sales?
A. For dermatology, the revenue structures of general and cosmetic dermatology serve as valuation criteria. For practices without beds, it’s typically 0.5 to 1.5 times annual revenue, and for practices with beds or hospital-scale facilities, it’s around 3 to 7 times EBITDA. We can provide a detailed estimate through a free preliminary assessment.
Q. What are the key points to consider when proceeding with a Regional Medical Collaboration Promotion Corporation?
A. Prior planning that considers its use as an alternative to M&A is essential. Successful execution relies on thorough practical implementation through collaboration with experts.
Q. Will my consultation be known to my staff or patients?
A. Information is disclosed on a limited basis after signing an NDA, and no disclosure to related parties is made before the final agreement. We strictly adhere to confidentiality.
Related Columns
- Complete Guide to Business Succession for Hospitals and Medical Corporations | Medical M&A Practices from Successor Shortages to Success Stories
- Complete Guide to Selling or Transferring a Clinic | Medical M&A Experts Explain Market Prices, Procedures, and Precautions
- How to Proceed with Medical M&A and Hospital Succession | Explaining the 6 Steps from Consultation to Closing with Real Examples
- Complete Guide to Tax Schemes for Medical Corporation M&A | Key Issues for Tax Accountants and CPAs
Consult with M&A Medical for Dermatology Regional Medical Collaboration Promotion Corporations
Strict Confidentiality, Free Initial Consultation, Success Fee Basis